Centene Corporation $CNC Shares Sold by Integrated Quantitative Investments LLC

Integrated Quantitative Investments LLC decreased its stake in Centene Corporation (NYSE:CNC) by 67.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,928 shares of the company’s stock after selling 14,215 shares during the period. Integrated Quantitative Investments LLC’s holdings in Centene were worth $247,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Addison Advisors LLC lifted its position in shares of Centene by 455.6% during the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company’s stock valued at $26,000 after acquiring an additional 606 shares during the period. Mowery & Schoenfeld Wealth Management LLC purchased a new position in Centene in the 3rd quarter valued at approximately $27,000. WPG Advisers LLC raised its holdings in Centene by 44.5% during the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after purchasing an additional 282 shares during the last quarter. Bogart Wealth LLC boosted its position in Centene by 11,011.1% during the third quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock worth $36,000 after purchasing an additional 991 shares in the last quarter. Finally, Financial Network Wealth Advisors LLC increased its position in shares of Centene by 54.9% in the third quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock valued at $39,000 after buying an additional 390 shares in the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Stock Down 3.8%

Shares of NYSE CNC opened at $43.28 on Friday. The firm’s 50 day moving average price is $43.18 and its 200 day moving average price is $37.96. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.10 and a current ratio of 1.10. The firm has a market cap of $21.28 billion, a P/E ratio of -3.18, a price-to-earnings-growth ratio of 1.01 and a beta of 0.48. Centene Corporation has a 1 year low of $25.08 and a 1 year high of $66.03.

Centene (NYSE:CNC) last posted its quarterly earnings data on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.22) by $0.03. The business had revenue of $49.73 billion for the quarter, compared to analysts’ expectations of $48.41 billion. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The business’s revenue was up 21.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.80 earnings per share. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, sell-side analysts anticipate that Centene Corporation will post 6.86 earnings per share for the current year.

Analyst Ratings Changes

Several research firms recently commented on CNC. Wells Fargo & Company set a $44.00 price objective on shares of Centene and gave the stock an “equal weight” rating in a research report on Wednesday, February 18th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $59.00 price target on shares of Centene in a report on Tuesday, January 6th. TD Cowen raised their price objective on shares of Centene from $34.00 to $38.00 and gave the stock a “hold” rating in a research note on Wednesday, February 11th. Robert W. Baird upped their target price on Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Centene from $32.00 to $39.00 and gave the stock a “hold” rating in a research report on Tuesday, February 10th. Three investment analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, Centene presently has a consensus rating of “Hold” and an average target price of $42.44.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.